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Available online xxxxBenzylpiperazine (BZP) is a novel psychoactive substance that is commonly abused in tablet form as an “ec-
stasy-type” drug. Electroanalysis offers genuine potential for field testing of bulk drug samples. This re-
search is the first to investigate the viability of voltammetric analysis of BZP. Initial cyclic voltammetry in
0.1 M KCl showed an oxidative peak at a glassy carbon electrode for BZP at approximately 0.8 V (scan
rate 205 mV s−1). Next an optimised electrode/electrolyte combination (viz. 80:20 W:W glassy carbon
beads:nujol and pH 9.5, 40 mM, Britton-Robinson buffer) was developed using K3Fe(CN)6 to test the
electrode material. The oxidation of BZP involves two electrons and two protons and a mechanism has
been proposed. An anodic stripping square wave voltammetric method was optimised by factorial design
with the conditions of deposition: −0.8 V for 135 s, and stripping: step height 10 mV, amplitude 50 mV
and frequency 13 Hz. A limit of detection of 6 μM was achieved. The resolution against 3,4-
methylenedioxymethylamphetamine (MDMA) was also verified.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Voltammetry
Forensic
Controlled drugs
Benzylpiperazine
Ecstasy1. Introduction
The abuse of ecstasy tablets came to prominence across Europe
during the late 1980′s at which time the major active ingredient
was 3,4-methylenedioxymethylamphetamine (MDMA) [1]. Howev-
er over the years clandestine laboratories have sought to circumvent
the law by producing tablets containing compounds which were not
under control. This has led to an enormous range of compounds
being seized worldwide. In fact, the 2015 World Drugs Report esti-
mates 500 compounds are abused globally [2]. In order to deal with
such a vast issue the United Kingdom introduced the Psychoactive
Substances Act 2016 wherein such a substance was defined as that
which “produces a psychoactive effect in a person if, by stimulating
or depressing the person's central nervous system, it affects the
person's mental functioning or emotional state” [3]. Although the
substances are defined by their action rather than their structure,
there are broad families of compoundswhich are commonly encoun-
tered namely: aminoindanes, synthetic cannabinoids, cathinones,
ketamine and phencyclidine-types, phenethylamines, piperazines
and tryptamines [4]. Further to this, the generality of the terminolo-
gy in the legislation enables law enforcement to seize any New. This is an open access article underPsychoactive Substances (NPSs), as they are commonly known,
resulting in a wide array of compounds which are presented for
analysis to forensic agencies. An excellent overview which outlines
the recent analytical strategies undertaken is given by Smith et al.
[5].
Benzylpiperazine (BZP) is one such NPS, structure shown in Fig. 1.
The importance of BZP in Europe was first noted in the early part of
the 21st century as it was being sold as a “legal high” over the internet
[6]. There was also some confusion at the time with piperazines being
sold as “herbal highs” although they are entirely synthetic. This may
have been due to structural similarities with the pepper derived
compound piperidine [7]. Then in 2009 the European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA) advised that the
member states should control BZP stating: “due to its stimulant proper-
ties, risk to health, the lack ofmedical benefits and following the precau-
tionary principle, there is a need to control BZP, but the control
measures should be appropriate to the relatively low risks of the sub-
stance” [8]. In the UK, BZP and structurally related analogues were
brought under control of the Misuse of Drugs Act 1971, being listed as
Class C in 2009 [9].
There already exists a wide array of chromatographic analytical
methodologies in the scientific literature regarding the analysis of
BZP. A brief synthesis of the analysis of BZP in a range of matrices is
shown in Table 1. Typical limits of detection (LOD) tend to be in
the nanomolar range, and this is indeed necessary for the analysisthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Structure of benzylpiperazine (BZP).
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noted that the methods are normally accompanied by a prior extrac-
tion step in order to attain LOD values in this range. It is also
noteworthy that expensive, lab based instrumentation is required
for this type of analysis which makes it unsuitable for field testing
of bulk drugs.
Consequently a number of presumptive tests have been
developed that can detect the presence of BZP. One such novel pre-
sumptive spot test was developed by Philp et al. [10] using sodiumTable 1
Chromatographic analytical methodologies for the analysis of BZP.
Matrix Extraction and derivatisation Analytical con
Urine Enzymatic hydrolysis with 100 mM acetate buffer
containing sulfatase/β-glucuronidase, then solid phase
extraction with Oasis HLB
Liquid Chroma
Acetate Buffer
mass analyser
Gas Chromato
1.0 mL min−1
Tablets and
capsules
10 min ultrasonication in 20 mM HCl:MeOH 1:1 v:v Liquid Chroma
(150 mm × 4.
v:v:v at 1 mL m
Gas Chromato
1.1 mL min−1
Plasma and
urine
Centrifugation then deproteinized with 35% ZnSO4 plus
enzymatic hydrolysis of urine
Liquid Chroma
gradient using
MSD model D
Plasma Dilution with pH 6 Phosphate buffer then solid phase
extraction using Chromabond Drug
Liquid Chroma
(150 mm × 2
and 0.1% CHOO
analyser
Simulated
Wastewater
Filtration the SPE using XRDAH506 Liquid Chroma
(50 mm × 4.6
0.5 mL min−1
Simulated
tablets
Dilution only for liquid chromatography and
heptafluorobutyric acid derivatisation and silylation
using SilPrep for gas chromatography
Liquid Chroma
gradient using
Gas Chromato
using SilPrep®
1.0 mL min−1
Urine Liquid/liquid extraction using KOH Gas Chromato
column (20 m
analyser
Urine Centrifugation then solid phase extraction using SOLA
SCX
Liquid Chroma
gradient elutio
0.4 mL min−1
system couple
Hair Overnight sonication in 0.1% HCOOH Liquid Chroma
gradient elutio
1:1 v:v MeOH
mass spectrom
Tablets Dissolution in water then freeze dried overnight Liquid Chroma
(250 mm × 10
MeCN at 3 mL
Gas Chromato
2 mL min−1; A
Tablets Unltrasonication in 2-methyl-propan-2-ol then
centrifugation
Gas Chromato
(30 m × 0.25
Turbomass Go
Wastewater Solid phase extraction using Oasis MCX. Gas Chromato
Supelco Equity
PerkinElmer C1,2-naphthoquinone-4-sulphonate to produce a dark red colour for
BZP. The proposed reaction scheme for this test is shown in Fig. 2.
They subjected the test to rigorous validation against many active in-
gredients and excipients commonly found in ecstasy-type seizures
and were also able to determine an LOD of 40 μg, which is more
than sensitive enough for its purpose. Piperidine has long been
known to be a precursor for phencyclidine [11] and as such has
been monitored closely. In a United Nations Scientific and Technical
Note the formation of a blue-coloured Simon-Awe complex is de-
scribed, as shown in Fig. 3 [12]. Almost all piperazines contain the
same activemoiety as piperidine and as such this general test for sec-
ondary amines could be applied. It is in fact the amine functionality
that enables colorimetric detection for all the common presumptive
tests [6].
Microcrystalline identification does not offer as low an LOD as the
colorimetric spot tests, but the growing habits that are observed be-
tween reagents and drugs can be very specific [13]. Elie et al. [14] de-
signed a microcrystalline assay for BZP using mercury chloride as the
reagent. Upon gentle mechanical assistance for nucleation, BZP was
found to form distinctive rectangular plates.ditions Limit of
detection
Reference
tography: SCX column (150 mm × 2 mm); 40 mM pH 4
:MeCN 25:75 v:v at 0.15 mL min−1; Shimadzu LCMS 2010A
30 nM [33]
graphy: DB-5MS column (30 m × 0.25 mm × 0.25 μm); He
; Shimadzu GCMS QP-2010 mass analyser
300 nM
tography: L-column ODS or SymmetryShield R18
6 mm × 5 μm); 10 mM SDS in MeCN:H2O:H3PO4 300:700:1
in−1; Diode array detector at 199–360 nm
Not
given
[34]
graphy: DB-5MS column (30 m × 0.25 mm × 0.25 μm); He
; Agilent N3520 mass analyser
Not
given
tography: Zorbax C18 column (150 mm × 4.6 mm × 5 μm);
0.01 M pH 4.5 NH4CHOO and MeCN at 1 mL min−1; Agilent
single stage quadrupole mass analyser
30 nM [35]
tography: Synergi Polar RP column
mm × 4 μm); gradient using 0.1% CHOOH in 1 mM NH4CHOO
H in MeOH at 0.25 mL min−1; Sciex API 365 tandem mass
30 nM [36]
tography: Luna pentafluorophenyl column
mm × 3 μm); gradient using MeOH and 0.1% CHOOH at
; AB Sciex Q-Trap mass analyser
6 pM [37]
tography: Hypersil C18 column (125 mm × 3 mm × 3 μm);
pH 3.2 PB and MeCN at 0.4 mL min−1; DAD at 210 to 400 nm
50 μM [38]
graphy: heptafluorobutyric acid derivatisation and silylation
; HP-5MS column (30 m × 0.25 mm × 0.25 μm); He
; Agilent 5971A mass analyser
3 μM
graphy: pentafluoropropionic anhydride derivatisation; J&W
× 0.18 mm × 0.18 μm); He 1.0 mL min−1; Agilent 5975 mass
150 nM [39]
tography: Accucore C18 (100 mm × 2.1 mm × 2.6 μm);
n using 0.1% HCOOH in water and 0.1% HCOOH in MeCN at
; Thermo Scientific NCS-3500RS UltiMate 3000 Binary Rapid
d to a Thermo Scientific Q Exactive Mass spectrometer
6 nM [40]
tography: Kinetex C18 column (100 × 2.1 mm × 2.6 μm);
n using 0.1% HCOOH in 5 mM NH4HCOO and 0.1% HCOOH in
: MeCN at 0.35 mL min−1; Agilent 6460 triple quadrupole
eter
5 pg/mg
of hair
[41]
tography: Synergi Hydro-RP Phenomenex column
mm); gradient elution using 0.05% CF3COOH in water and
min−1; UV detection at 208 nm
Not
given
[42]
graphy: DB1-ms column (15 m × 0.25 mm × 0.25 pm sic); He
gilent 5975C MSD Series with a Triple-Axis Detector
Not
given
graphy: Supelco Equity 5 column
mm × 0.25 μm); He 1 mL min−1; Perkin Elmer Clarus
ld 500MS detector.
2 nM [43]
graphy: Pentafluoropropionic anhydride derivatisation;
TM-5 column (30 m × 0.25 mm × 0.25 μm); He 1 mL min−1;
larus 500 Gas Chromatograph-Mass Spectrometer detector
0.14 pg
on
column
[44]
Fig. 2. Reaction scheme for the BZP presumptive colour test which uses 1,2-naphthoquinone [7].
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amine [15]. Notwithstanding BZP acting on the same receptors as
amphetamine, it may not bind to the same antibodies as those used
in amphetamine immunoassays. The response of several piperazines
was checked against an enzyme-multiple immunoassay technique
(EMIT) and a fluorescence polarisation immunoassay (FPIA) initially
designed for amphetamine and methylamphetamine [16]. The FPIA
did not detect BZP in a 100,000 ng mL−1 spiked urine sample.
However the amphetamine EMIT did respond to BZP with cross reac-
tivities of 0.4% and 1.3% at 300 and 12,000 ng mL−1 amphetamine
equivalents respectively. There are currently no commercially
available immunoassays specifically for piperazines [6], however
some recent literature has been published to this effect [17]. Also in
general with presumptive testing false positives are possible [18]
and they are at best semi-quantitative [19].
There can be no doubt as to the general reliability of electrochemical
measurements in light of the facts that: globally amperometric quanti-
tation of glucose is relied upon by millions of diabetes patients [20],
there is widespread use of fuel-cell breath-alcohol testers by police
forces [21] amongst many other medical applications [22]. The major
advantages of electrochemical analysis over other techniques can be
summarised as:
• Miniaturisation enables portability and the analysis of samples of very
small volume [23].
• Through proper electrode design a high level of sensitivity, selectivity
and stability can be achieved [24].
• The analysis is generally faster and simpler than other techniques [25].
• It is far cheaper thanmost other techniques with comparable limits of
quantification (LOQ) [26].
These benefits could of course be useful in field testing in a foren-
sic context and indeed the relatively new field of “forensic electro-
chemistry” has found a range of applications in recent years [27]
including the voltammetric analysis of gunshot residue using an
innovative “lab-on-a-finger” technique [28], and explosives [28].
However the bulk of the published forensic electrochemistry
research lies in the area of drug analysis. Some recent highlights
from this are presented in Table 2.
It was the aim of this research to assess the viability of voltammetric
analysis of BZP as the technique lends itself sowell to potentialfield use.
This research comprises the first time the voltammetric analysis of BZP
has been reported.Fig. 3. Reaction scheme for the United2. Experimental
2.1. Materials
All voltammetric analysis was carried out using a PGStat128N
potentiostat in combination with the NOVA software v1.11 (both
Metrohm Autolab). An Ag|AgCl reference electrode and a Pt sheet
counter electrode were used for all analysis (both Metrohm
Autolab). A 2 mm diameter graphite electrode (Metrohm Autolab),
a 2 mm diameter gold and a 2 mm diameter platinum electrode
(both BASi) were cleaned with an aqueous slurry using 15 μm alumi-
na (Microabrasives Corp.) then sonicated in de-ionisedwater for 60 s
prior to use as the solid working electrodes for the initial investiga-
tion. Three carbon powders of different particle sizes (all Aldrich)
and Nujol (Plough UK) were used to form the paste electrodes. The
respective ratios of carbon and nujol were triturated for 20 min in a
pestle and mortar prior to being housed in a Teflon electrode
(BASi) with a 3 mm exposed area. A Zeiss EVO LS scanning electron
microscope (SEM) was used to capture images of the carbon pow-
ders. The chemicals used in the preparation of the background elec-
trolytes were all laboratory reagent grade (Fischer Scientific) and
used without any further purification. Background electrolytes
were thoroughly degassed by nitrogen bubbling. The potassium fer-
ricyanide was a laboratory reagent of 99% purity. A liquid BZP stan-
dard of purity ≥90% (Bione) was used for the analysis with the
solid electrodes and a BZP hydrochloride salt, ≥98% (Cayman
Chemicals) was used in the analysis using the paste electrodes. A
3,4-methylenedioxymethylamphetamine (MDMA) hydrochloride
salt standard of purity ≥98% (Sigma) was used to assess the selectiv-
ity of themethod. All drug concentrations are reported as base rather
than as the salt. Deionisedwater with a resistivity of 18.2MΩ cmwas
used to prepare the solutions. The software Minitab v16 (Minitab
Inc.) was used to produce and analyse the factorial design
experiment.2.2. Initial investigation
A 10mL cell volume of approximately 50 μMBZP in 0.1 M KCl was
prepared and cyclic voltammograms (CVs) were run using the solid
graphite, gold and platinum electrodes and each was checked
against an appropriate blank. Five scans in total were taken for
each cell using a scan rate (υ) of 250 mV s−1 and a step height of
2.4 mV.Nations piperidine colour test [9].
Table 2
Recent voltammetric controlled drug research. New acronyms in table: WEworking electrode; THF tetrahydrofuran; HMDE hanging mercury drop electrode; BR Britton Robinson buffer;
AdSDPV adsorptive stripping differential pulsed voltammetry; GCE glassy carbon electrode; CV cyclic voltammetry; OCP open circuit potential; SCE saturated calomel electrode; LSV linear
sweep voltammetry; AdSSWV adsorptive stripping square wave voltammetry; SWV square wave voltammetry; ITO indium tin oxide; SAM self assembled monolayers; MWCNT
multiwalled carbon nanotubes.
Analyte/s and (matrix) Extraction WE and (technique) Analytical conditions LOD
(ng mL−1)
Ref
Morphine and noscapine
(plasma)
Centrifuged and vortexed with
0.7 M ZnSO4, bicarbonate and
THF
HMDE
(AdSDPV)
BR pH 10; deposition at -100mV vs. Ag|AgCl
for 150 s, then stripped from 100 to 400 mV
at 40 mVs−1 with amplitude 100 mV
morphine 3
noscapine 7
[45]
Morphine
(urine)
Dilution only GCE
(CV)
50 mM PB at pH 7.4; stirred accumulation
at OCP for 90s, then CV from 0 to 700 mV
vs. Ag|AgCl at 100 mV s−1
57 [46]
MDMA
(standards only)
– GCE
(CV)
50 mM PB at pH 7.4; scanned 1000 to
−500 mV vs. SCE
– [47]
Cocaine
(powder)
Dilution only PDE modified with cobalt
hexacyanoferrate (LSV)
0.1 M NaClO4 in MeCN; 0 to 1200 mV at
100 mV s−1 vs. Ag|AgCl
43 [48]
Zopiclone
(urine and Imovane® tablets)
Tablets were crushed and
centrifuged in H2O
GCE
(AdSSWV)
BR pH 7.08; deposition at 600 mV vs.
Ag|AgCl for 120 s, then stripped from 200
to 1400 mV with amplitude 50 mV,
frequency 50 Hz and step 10 mV.
66 [49]
Clonazepam, flurazepam,
alprazolam, midazolam,
medazepam,
chlordiazepoxide and
diazepam (phytotherapeutic
formulations)
Dilution in MeOH HMDE
(AdSDPV)
Ringer buffer pH 10.0; 10 s deposition at
varying potential depending on analyte
from −400 to−800 mV vs. Ag|AgCl and
subsequent varying sweeps, using pulse
amplitude -50 mV, pulse duration 40 ms,
scan rate 50 mV s−1
– [50]
Amphetamine, MEA, MDA,
MDMA
(serum and tablets)
Tablets sonicated for 5 min in
H2O and filtered. MeOH added
to serum then vortexed and
centrifuged
GCE
(SWV)
0.2 M PB pH 7; scan 0 to 1500 mV vs.
Ag|AgCl with frequency 100 Hz and pulse
amplitude 50 mV
MDMA 464 [51]
Morphine
(standards only)
– ITO modified with
poly(3,4-ethyleenedioxythiophene) and
further activated with IrO2
(LSV)
0.5 M sulphate buffer pH 2; scan 0 to
1300 mV vs. Ag|AgCl at 50 m V s−1
– [52]
Cocaine
(standards only)
– ITO modified by SAM of ferrocene and Au
nanoparticles and activated with cocaine
aptamer fragment SH-C2
(DPV)
0.1 M PB pH 6.5; scan 700 to 0 mV vs.
Ag|AgCl with modulation time 50 ms,
interval time 0.5 s, modulation amplitude
25 mV and potential step 5 mV.
30 [53]
Morphine
(urine)
Centrifuged and diluted with
PB pH 8.0
MCPE using graphite: MWCNT 4:1 w:w
in paraffin oil with
1-butyl-3-methylimidazolium
hexafluoro phosphate binder
(DPV)
0.1 M PB pH 8.0; scan 100 to 600 mV vs.
Ag|AgCl with pulse height 100 mV and
pulse width 5 mV.
40 [54]
Morphine
(serum)
Dilution only GCE modified with Au nanotube array on
an anodic aluminium oxide template
(DPV)
0.1 M phosphate and citric acid buffer
pH 6.1; other parameters not specified
12 [55]
MCPE modified carbon paste electrode; HRP horseradish peroxidase; THC Δ9-tetrahydrocannabinol
Cocaine
(serum)
Dilution with 10 mM PB
pH 7.4 and 1 M NaCl
Au electrode modified by tetrahedron
SAM of thiolated aptamers
(Chronoamperometry)
Cocaine fuses the aptamers aca-1 and
biotinylated aca-2. This is followed by the
binding of avidin-HRP conjugates to aca-2′s
biotin tag. As HRP can now act as a catalyst
for H2O2 reduction in the presence of
3,3′,5,5′-
tetramethylbenzidine an amperometric
signal is produced
10 [56]
Codeine
(tablets)
Crushed and dissolved in
0.2 M AB pH 4.5
GCE
(SWV)
0.2 M AB pH 4.5; scan 0 to 1800 mV vs.
Ag|AgCl with frequency 75 Hz, amplitude
50 mV and increment 5 mV
761 [57]
Morphine
(urine)
Dilution only MCPE using electrodeposition of
ferrocene and Au nanoparticles
(DPV)
0.04 M BR pH 7.4; scan 100 to 600 mV vs.
Ag|AgCl with scan rate 10 mV s−1 pulse
width 25 ms, pulse period 200 ms and
pulse amplitude 10 mV
1 [58]
Morphine
(urine)
Centrifuged and diluted with
PB pH 7.0
MCPE using graphite:MWCNT:
n-hexyl-3-methylimidazolium
hexafluorophosphate 64.5:15.5:20
w:w:w in paraffin oil
(DPV)
0.1 M PB pH 7.0; scan 300 to 600 mV vs.
Ag|AgCl with pulse height 80 mV and
pulse width 7 mV
6 [59]
THC
(hemp and hashish)
10 min US in MeOH then
filtered. Filtrate then subject to
preparative TLC
GCE
(LSV)
0.1 M tetrabutylammonium
tetrafluoroborate in N,N-
dimethylformamide:H2O 9:1 v:v; 30s
deposition at−1200 mV vs. Ag|AgCl then
scan −1000 to 500 mV at 100 mV s−1
0.34 [60]
Morphine
(urine and pharmaceutical
formulations)
Urine was filtered prior to
dilution in 0.15 PB pH 7.0
MCPE using
graphite:MWCNT:4-hydroxy-2-
(triphenylphosphino)phenolate
200:2:1 w:w:w in paraffin oil
0.15 M PB pH 7.0; other parameters not
specified
19 [61]
(continued on next page)
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Table 2 (continued)
Analyte/s and (matrix) Extraction WE and (technique) Analytical conditions LOD
(ng mL−1)
Ref
(DPV)
Morphine, noscapine and
diamorphine
(standards only)
– GCE modified with graphene nanosheets
(DPV)
0.1 M PB pH 8.0; scan from 100 to
1100 mV vs. Ag|AgCl with voltage step
8 mV, scan rate 20 mV s−1 and pulse
amplitude 50 mV
morphine
114
noscapine 83
diamorphine
185
[62]
Morphine
(standards only)
– Au electrode by SAM of
2-aminoethanethiol
(CV)
0.2 M PB pH 6.0; scan 0 to 800 mV vs.
Ag|AgCl at a range of scan rates
− [63]
Morphine
(urine)
Dilution only MCPE using graphite:Al2O3 nanoparticles
9:1 w:w in paraffin oil
(SWV)
0.1 M PB pH 7.0; other parameters not
specified
9 [64]
GHB
(standards only)
– Pt
(CV)
0.1 M HClO4 and 0.1 M H3PO4; scan−200
to 1200 mV vs. Ag|AgCl at 10 mV s−1
− [65]
Codeine
(urine)
Centrifuged and diluted with
PB pH 4.0
GCE modified with graphene and Nafion
(SWV)
0.1 M PBS pH 4.0; stirred accumulation at
OCP for 180 s then scan 700 to 1300 mV
using amplitude 50 mV, step height 6 mV
and frequency 12 Hz
5 [66]
Cocaine
(standards only)
– Pt electrode modified with
[UO2(N,N′’-Ethylenebis(3-
methoxysalicylideneaminato))(H2O)]∙
H2O (CV)
1 M KCl and 0.001 M HCl; scan−300 to
400 mV vs. Ag|AgCl at 100 mV s−1
21 [67]
New acronyms in table: GHB γ-hydroxybutyric acid; PBS phosphate buffered saline; CPE carbon paste electrode; SDS sodium dodecyl sulphate
Buprenorphine
(urine)
Dilution only CPE
(DPV)
0.24 mM SDS in 0.2 M PB pH 3.0; stirred
accumulation
at OCP for 120 s then scan
300 to 1000 mV with pulse height 10 mV
and scan rate 90 mV s−1
7 [68]
Morphine
(urine and pharmaceutical
samples)
Centrifuged and filtered prior
to dilution
MCPE using graphite: NiO modified
MWCNT: 1-methyl-3-butylimidazolium
chloride 70:35:25 w:w:w in paraffin oil
(SWV)
0.1 M PB pH 7.0; other parameters not
specified
3 [69]
Morphine
(serum and urine)
Dilution only GCE modified with electrochemically
reduced MWCNT graphene oxide
(LSV)
0.1 M PB pH 4.5; stirred accumulation at
OCP for 120 s then scan 200 to 900 mV at
100 mV s−1
14 [70]
Morphine
(urine)
Supported liquid membrane
extraction using 2-nitrophenyl
octyl ether containing 10%
tris-(2-ethylhexyl) phosphate
and 10% di-(2-ethylhexyl)
phosphate
Carbon SPE
(DPV)
0.1 M NaOH; scan 0 to 600 mV vs. Ag
pseudoreference with step 15 mV and
pulse amplitude 50 mV
2 [71]
Methadone
(urine and saliva)
MeCN was added to urine then
all samples were vortexed and
centrifuged
MCPE using graphite:MWCNT 65:10 w:w
then electrodeposition of Au
nanoparticles
(AdSSWV)
0.04 M BR pH 9.0; deposition at 700 mV vs.
Ag|AgCl for 100 s then scan 500 to
1250 mV with pulse amplitude 100 mV
and frequency 25 Hz
5 [72]
Cocaine
(powder)
Dilution only Carbon SPE modified with MWCNT
(SWV)
0.1 M PBS pH 10; scan 0
to 1500 mV vs Ag|AgCl with step potential
12 mV, frequency 25 Hz and
amplitude 25 mV
– [72]
MDMA
(Standards only)
– GCE modified with Nafion and
cucurbit[6]uril
(CV)
KCl solution; scan 800 to 1300 mV at
100 mV s−1
3 [73]
Methcathinone, mephedrone
and 4-MEC
(standards only)
– Carbon SPE
(CV)
PB pH 2; scan 0 to 1700 mV vs. SCE at
100 mV s−1
methcathino-
ne 44500
mephedrone
39800
4-MEC
84200
[30]
Morphine
(serum)
MeCN was added to serum
then samples were vortexed
and centrifuged
GCE modified with Nafion and MWCNT
(AdSSWV)
0.1 M H2SO4; deposition at -500 mV vs.
Ag|AgCl for 360 s then scan 700 to
1400 mV with potential step 8 mV,
frequency 75 Hz and amplitude 25 mV
9 [74]
Morphine and codeine
(serum and urine)
Urine was centrifuged and
filtered. Serum had 20% v:v
HClO4 added, vortexed then
centrifuged
Pencil graphite electrode modified with
PDDA and aptamers
(AdSDPV)
0.1 M PB pH 7.0; stirred accumulation at
OCP for 300 s then scan from 0 to 900 mV
with pulse amplitude 50 mV, modulation
time 0.05 s and step potential 8 mV
morphine 41
codeine 43
[75]
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In order to investigate the effects of particle size, allotrope, and or-
ganic binder, three different forms of carbon powder were each mixed
in two different ratios with nujol as shown in Table 3. Although thisstudy is not exhaustive, its reduced form does permit a comparison be-
tween graphite and glassy carbon alongside a threefold difference in
particle size. SEM images of the three carbon powders were captured
using the secondary electron detector under high vacuumwith a work-
ing distance of 10 mm and an anode potential of 25 kV. A 10 mM
Table 3
Ratios of carbon to nujol used in assessment of paste electrodes.
Paste
number
Allotrope of
carbon
Particle size
(μm)
Carbon
(%W/W)
Nujol
(%W/W)
1 Graphite b45 60 40
2 Graphite b45 80 20
3 Graphite b150 60 40
4 Graphite b150 80 20
5 Glassy carbon 2–12 60 40
6 Glassy carbon 2–12 80 20
Table 4
Factorial design for optimisation of square wave voltammetry of BZP using Paste 6.
Run order Step (mV) Amplitude (mV) Frequency (Hz)
1 10 5 5
2 1 5 50
3 10 5 50
4 1 50 5
5 10 50 50
6 1 5 5
7 1 50 50
8 10 50 5
Fig. 4. CV of 50 μM BZP using graphite (GCE), gold (Au) and platinum (Pt) electrodes. The
second scan of five is shown in each case and platinum is shown as off scale for clarity of
the important oxidative peaks (υ= 250 mV s−1).
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standard addition analysis by square wave voltammetry (SWV). The
concentration range 99 to 909 μM of K3Fe(CN)6 in 0.1 M KCl was tested
for each paste electrode using the voltage programdeposition at−0.5 V
for 30 s then stripping up to 1.0 V with a step of 5 mV, amplitude of
20 mV and a frequency of 25 Hz. Three CVs were also obtained for theFig. 5. SEMmicrographs of carbon powder. The particle size is shown in the top left of each imag
carbon.99 μM of K3Fe(CN)6 cell using three scan rates: 10, 100 and
500 mV s−1. The particular study was limited to three different rates
as it was not deemed necessary to examine the [Fe(CN)6]3−/2− redox
process in detail. It was however deemed informative to gain values
for the slope of the Randles-Sevcik plot for each paste for comparison.
In each CV the working electrode potential started at 0.0 V and was
swept to 1.0 V then cycled between −0.7 V and 1.0 V a total of 3
times with a step of 2.4 mV.
2.4. Mechanism investigation
Seven separate Britton-Robinson (BR) buffers at 40 mM were pre-
pared to cover the pH range 4 to 10. These were used as the background
electrolyte for 49 μM BZP cells. Each pH cell was investigated by linear
sweep voltammetry (LSV) using the Paste 6 working electrode from
−0.8 V to 1.0 Vwith a scan rate of 500mV s−1 and step of 2.4mV. A fur-
ther BR buffer at pH 9.5was also prepared as the background electrolyte
for a 67 μmBZP solution in order to assess the LSV over the same poten-
tial range but with varying scan rates of 10, 25, 50, 100, 250, and
500 mV s−1 using the Paste 6 electrode.
2.5. Method development
A 100 μM BZP was prepared in pH 9.5 BR buffer and analysed by
SWV using the Paste 6 electrode. Increasing levels of deposition time
were tested in order to assess when electrode saturation occurred. Oth-
erwise the working electrode was swept from−0.8 V to 1.0 V with a
step of 5 mV, and amplitude of 20 mV and a frequency of 25 Hz. Once
the best deposition time was determined the SWV was further
optimised with the same cell using a factorial design as shown in
Table 4.
2.6. Method validation
The optimised SWVmethod was used to analyse BZP solutions over
the concentration range 10 to 60 μM BZP in pH 9.5 BR buffer using the
Paste 6 electrode. 500 mL of Pepsi Cola ® was degassed by sonication
for 20min then 20min nitrogen bubbling. 10.8mgof BZP hydrochloride
was dissolved in 100 mL of the cola and analysed in triplicate using the
optimised SWVmethod. A 3 μMMDMA solution in pH 9.5 BR buffer was
analysed by the optimised SWVmethod in order to assess the selectivity
of the method against the most commonly encountered ecstasy-type
compound.
3. Results and discussion
3.1. Electrode material determination
The three CVs for the initial scan of BZP are shown in Fig. 4. Platinum
did not show any response to BZP that was not also present in the blanke and the scale is shown in the bottom left. Image A and B are graphite and image C is glassy
Table 5
Summary of assessment data for K3Fe(CN)6 in 0.1 M KCl for the five functional paste electrodes. The CV data in the columns two and three was measured at 99 μM.
Paste number CV
ΔEp at 100 mV s−1 (V)
CV
Ratio of slopes from Randles-Sevcik plots
SWV
Sensitivity (A M−1)
SWV
RSD of Peak Potential (%)
1 0.90 1.1 3.69 × 10−4 1.43
2 0.45 0.4 5.69 × 10−3 1.18
3 0.55 0.6 2.75 × 10−3 0.73
4 0.80 No reduction peak observed 2.58 × 10−3 0.88
6 0.08 0.9 4.79 × 10−2 0.00
Fig. 6. CVs on the left and corresponding Randles-Sevcik plots on the right for the five functional electrodes using 99 μM K3Fe(CN)6 in 0.1 M KCl (υ= 500 mV s−1 in scans shown). The
composition for the paste number in the top left of each is given in Table 2.
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Fig. 7. SWVson the left and the corresponding regression plots for varying concentrations of K3Fe(CN)6 in 0.1MKCl. The composition for the paste number in the top left of each is given in
Table 2.
35S.A. Waddell et al. / Sensing and Bio-Sensing Research 13 (2017) 28–39CV sowas thus discarded from further investigation. The gold electrode
showed a reversible peak which was also present in the blank consid-
ered to be formation and removal of an oxide layer. However at approx-
imately 0.8 V a non-reversible oxidative peak was present whichcorresponded to BZP. This peak was also present in the graphite elec-
trode CV. Due to the response to graphite for BZP being highest of
those tested and the general wide applicability of carbon electrodes, it
was decided to pursue carbon as the electrode material.
Fig. 9. First differential of LSV analysis of 120 μMK3Fe(CN)6 at varying scan rate in pH 9 BR
buffer (n = 3).
36 S.A. Waddell et al. / Sensing and Bio-Sensing Research 13 (2017) 28–39The SEM images of the types of carbon that were investigated are
shown in Fig. 5. The two graphite powders had highly irregular mor-
phology but generally were within the particle size listed by the
manufacturer (as estimated by the SEM's sizing capability). However
the glassy carbon particles were muchmore regular being almost en-
tirely spherical and again falling within the manufacturer specified
size. The six different carbon paste electrodes were then evaluated
using K3Fe(CN)6 as a model compound as it is known to have excel-
lent reversibility characteristics. It was immediately discovered that
Paste 5 failed to produce any signal which is assumed to be due to
lack of conductivity. The CVs for the five remaining paste electrodes
are shown in Fig. 6 alongside the Randles-Sevcik – plots of peak cur-
rent (IP) versus the square root of the scan rate – for each paste. The
most striking feature from the CVs is that Paste 6 shows by far the
most reversible characteristics; the peak to peak separations for
Pastes 1 to 4 are all N100 mV even at the slowest scan rate whereas
ideally for a reversible single electron transfer such as in the ferricy-
anide ion 60 mVwould be expected. Indeed Paste 6 is the only one to
have the cathodic wave in the positive potential region, although it
also has the highest background capacitance shown by the vertical
distance between the forward and reverse waves. The cathodic
Randles-Sevcik plot for Paste 4 was not determined because the
peak potential EPC was not distinctly formed against the background
wave. The cyclic data for the five functional pastes are summarised in
Table 5. As the peak to peak separation (ΔEP) for Paste 6 is clearly the
lowest and the ratio of the slopes for Paste 6′s cathodic and anodic
Randles-Sevcik plots is close to 1 it has the best reversibility charac-
teristics. The sensitivity of each of the pastes was also investigated by
SWV and the voltammograms alongside the regression curves are
shown in Fig. 7. Table 5 also summarises the two important features
from the SWV data namely Paste 6 has a sensitivity which is at least
an order of magnitude bigger than that of the other pastes and the
precision of the peak potential in Paste 6 is impeccable – it was the
same value for each concentration. As Paste 6 clearly had the fastest
heterogeneous electron transfer, as shown by its reversibility and
sensitivity, it was chosen for the subsequent analysis when the
focus of the research returned to BZP.3.2. Mechanism of BZP oxidation
The data for the LSV analysis at varying pH is shown in Fig. 8, how-
ever it should be noted that the first differential of the current with re-
spect to the potential has been plotted for clarity. It was noted that EP
decreased with increasing pH according to the relationship EP
(V) = −0.062 × pH + 1.353 (V) (R2 = 0.98). The closeness of the
slope to −0.059 V pH −1 indicates that an equal number of electrons
and protons are involved in the charge transfer mechanism by analogy
to the Nernst equation. Other than decaying at either extreme of theFig. 8. First differential of LSV analysis of 49 μM K3Fe(CN)6 at varying pH. Inset shows the
regression of line for how Peak Potential (EP) changes with pH (n = 3).pH scale there did not appear to be a clear relationship between IP and
pH. Therefore the pH value of 9.5 was chosen for further analysis
which is close to the pKa value of BZP (literature value 9.59 [29]). This
pH serves two advantages: a relatively low value of EP is used meaning
there is less chance of also oxidising interfering compounds and a rela-
tively high IP is maintained. An EP – pH relationship such as this also in-
dicates that it is the amine groupwhich is being oxidised rather than the
aromatic ring. The mechanism was further investigated by altering the
scan rates used in LSV and the results of which are shown in Fig. 9,
where again the first differential of current with respect to potential
has been plotted. This data indicated a diffusion limited process as
there was a linear relationship between the square root of the scan
rate and the peak current (IP (A) = 8.802 × 10−4 (υ V s−1)−0.5–
1.968 × 10−4 (A), with R2= 0.99). The peak potential (EP) was also ob-
served to shift to higher valueswith increasing scan rate and a linear re-
lationship was observed between the ln υ and EP (EP (V)= 0.0317 ln (υ
V s−1) + 0.7665 (V). In general the shift in peak potential for a
completely irreversible process with changing scan rate is given by Eq.
(1) [30]:
EP ¼ E∘f−
RT
αnF
ln
RTk∘
αnF
þ RT
αnF
lnυ ð1Þ
where Ef∘ is the formal potential, R, T and F have their usual assignments,
α is the transfer coefficient, n is the number of electrons involved in the
charge transfer and ko is the heterogenous rate constant. Therefore by
analogywith the last term in Eq. (1) and the slope of the graph of EP ver-
sus ln υ, the value of αn can be estimated as 0.8. This data taken in its
entirety would seem to support an overall mechanism involving the
loss of two electrons and two protons. Therefore the proposed
mechanism as shown in Fig. 10 is consistent with the oxidation
of tripropylamine as described by Portis et al. [31]. This also
explains the complete irreversibility as the tertiary amine is lost at
the end of the mechanism due to a homogeneous reaction with the
solvent.
Fig. 10. Proposed two electron and two proton mechanism of BZP oxidation at the carbon paste electrode.
37S.A. Waddell et al. / Sensing and Bio-Sensing Research 13 (2017) 28–393.3. Optimisation of BZP oxidation at the paste electrode
The attention was then turned to optimising the SWVmethod for
the analysis of BZP. Increasing lengths of time were used for deposi-
tion to determine the point at which the electrode would become
saturated. The resulting data of peak current versus deposition is
shown in Fig. 11. It was obvious that there was no advantage toFig. 11. Investigation of SWV peak current with varying deposition time using the Paste 6
electrode for a 120 μM BZP in pH 9.5 BR buffer. The error bars are 1 standard deviation
(n = 3).increasing the deposition time beyond 135 s so this was used for sub-
sequent analysis. A full factorial design was then used to investigate
the effects of the SWV parameters: step height, amplitude, and fre-
quency. The results were interpreted both in terms of sensitivity
where the absolute value of the peak current was used and in
terms of precision where the relative standard deviation of the
peak current (n = 3) for each setting was used. It would found that
no one factor or combination of factors had a statistically
significant effect (at 95% confidence) over the others in terms of
sensitivity. However the step height, the frequency and the
combination of step height and frequency were found to have a
statistically significant effect in terms of precision. Both sensitivity
and precision were used in order to find the optimised value for
each parameter which was step height 10 mV, amplitude 50 mV
and frequency 13 Hz.
3.4. Validation of the optimised method
The validation of the method began with the analysis of range of
concentrations of BZP in order to assess linearity and the limit of de-
tection and quantification (LOD and LOQ). The regression data is
shown in Fig. 12. The method was shown to be linear between 12
and 68 μM (R2 = 0.99) beyond this range it was noted there was
slight deviation, however it was also noted that there was linearity
if tested over a higher range e.g. 100 to 200 μM (data not shown).
The LOD and LOQ were determined using the sum of the square of
the residuals method (i.e. 3 and 10 times the standard deviation of
the blank) and were found to be 6 and 20 μM respectively. As an ex-
ample application a 61 μM BZP in Pepsi Cola solution was tested
against a Pepsi Cola blank. The blank did not have any peaks in the
region of the BZP oxidation and the concentration was determined
by reference to the linear regression used in the LOD determination.
A comparison of the concentration by weight and the concentration
by calculation showed the values to agree to within 0.08% which was
excellent precision (n = 3). Lastly a solution of MDMA was analysed
Fig. 12. Regression calibration for BZP using the Paste 6 electrode in pH 9.5 BR buffer and
the optimised SWV method. The error bars are 1 standard deviation (n = 3).
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with BZP is shown in Fig. 13. It was noted that although the peaks
were not completely resolved there was a separation of 90 mV and
it would be possible to distinguish between them in combination
with the analysis of standards. The resolution was found to be 0.45
which was calculated by dividing the difference in peak potential
by the average peak width.
4. Conclusion
An analytical method has been developed which offers the prom-
ise of portability, cheapness, speed, precision and accuracy for the
analysis of BZP. Although there are many analytical techniques
which have superior LOD parameters, this becomes irrelevant in
the analysis of bulk drugs which is the future goal of this research.
An LOQ of 20 μM is more than sufficient considering the average
dose of a tablet is between 50 and 200 mg [32]. However if the anal-
ysis of body fluids for the presence of BZP using this technique was toFig. 13. Optimised SWV comparison using Paste 6 electrode in pH 9.5 BR buffer for 3 μM
MDMA and 12 μM BZP for comparison.be considered it would be important to assess the resolution be-
tween the hydroxylated metabolites and the drug itself.
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